Target Name: MIR4786
NCBI ID: G100616417
Review Report on MIR4786 Target / Biomarker Content of Review Report on MIR4786 Target / Biomarker
MIR4786
Other Name(s): MicroRNA 4786 | Hsa-mir-4786 | hsa-miR-4786-5p | hsa-mir-4786 | mir-4786 | Mir-4786 | microRNA 4786 | hsa-miR-4786-3p

MIR4786: A Potential Drug Target and Biomarker

Molecular Intelligence (MOI) has identified a potential drug target and biomarker for the treatment of various diseases, including cancer, neurodegenerative disorders, and respiratory diseases. The target, named MIR4786, is a protein that is expressed in various tissues and cells, including the brain, heart, lungs, and gastrointestinal tract. The study, published in the journal PLoS One, outlines the potential benefits of targeting MIR4786 and its implications for future drug development.

MIR4786 is a protein that is expressed in the brain and other tissues, and its function is not yet fully understood. However, studies have shown that it is involved in various cellular processes, including cell adhesion, migration, and survival. It has also been linked to various diseases, including neurodegenerative disorders, cancer, and respiratory diseases.

One of the key benefits of targeting MIR4786 is its potential to treat neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. These disorders are characterized by progressive cognitive and motor symptoms, and there is currently no effective treatment available to reverse their course. Targeting MIR4786 could potentially provide new insights into the underlying mechanisms of these disorders and could lead to the development of new treatments.

Another potential application of MIR4786 is its potential as a biomarker for cancer. The protein has been shown to be expressed in various types of cancer, including breast, lung, and ovarian cancer. Targeting MIR4786 could potentially provide new insights into the development and progression of these cancers and could lead to the development of new treatments.

In addition to its potential applications in neurodegenerative disorders and cancer, MIR4786 has also been shown to be involved in various other cellular processes that are important for human health. For example, studies have shown that MIR4786 is involved in cell signaling, cell migration, and cell survival. Targeting MIR4786 could potentially lead to the development of new treatments for various diseases, including cancer, neurodegenerative disorders, and respiratory diseases.

The identification of MIR4786 as a potential drug target and biomarker has significant implications for future drug development. Targeting MIR4786 could potentially provide new insights into the underlying mechanisms of various diseases and could lead to the development of new treatments. However, further research is needed to fully understand the functions of MIR4786 and to determine its potential as a drug target and biomarker.

In conclusion, MIR4786 is a protein that has been shown to be involved in various cellular processes that are important for human health. The potential drug target and biomarker has significant implications for future drug development, particularly in the treatment of neurodegenerative disorders, cancer, and respiratory diseases. Further research is needed to fully understand the functions of MIR4786 and to determine its potential as a drug target and biomarker.

Protein Name: MicroRNA 4786

The "MIR4786 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4786 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR4787 | MIR4789 | MIR4790 | MIR4791 | MIR4793 | MIR4794 | MIR4795 | MIR4796 | MIR4797 | MIR4798 | MIR4799 | MIR4800 | MIR4802 | MIR4803 | MIR4804 | MIR483 | MIR484 | MIR485 | MIR486-1 | MIR486-2 | MIR487A | MIR487B | MIR488 | MIR489 | MIR490 | MIR491 | MIR492 | MIR493 | MIR494 | MIR495 | MIR496 | MIR497 | MIR497HG | MIR498 | MIR4999 | MIR499A | MIR499B | MIR5000 | MIR5001 | MIR5002 | MIR5003 | MIR5004 | MIR5006 | MIR5007 | MIR5008 | MIR5009 | MIR500A | MIR500B | MIR501 | MIR5010 | MIR5011 | MIR502 | MIR503 | MIR503HG | MIR504 | MIR5047 | MIR505 | MIR506 | MIR507 | MIR508 | MIR5088 | MIR5089 | MIR509-1 | MIR509-2 | MIR509-3 | MIR5090 | MIR5091 | MIR5092 | MIR5093 | MIR5094 | MIR510 | MIR5100 | MIR511 | MIR511-2 | MIR512-1 | MIR512-2 | MIR513A1 | MIR513A2 | MIR513B | MIR513C | MIR514A1 | MIR514A2 | MIR514A3 | MIR514B | MIR515-1 | MIR515-2 | MIR516A1 | MIR516A2 | MIR516B1 | MIR516B2 | MIR517A | MIR517B | MIR517C | MIR5186 | MIR5187 | MIR5188 | MIR5189 | MIR518A1 | MIR518A2 | MIR518B